EATONTOWN, N.J., Nov. 11, 2019 /PRNewswire/ -- Caregility, a clinical collaboration and communications company changing the point of care, today announced the company's involvement in the ATLAS pil

LOS ANGELES, Calif., Nov. 11, 2019 /PRNewswire/ -- Four new Prostate Cancer Foundation (PCF) Centers of Excellence (COEs) have joined the PCF's dedicated network of centers executing the ambitious mission of improving the care for U.S. Veterans with prostate cancer. With the addition of the new centers, the PCF has established 10 COEs to date. Located in

TOLEDO, Ohio, Nov. 11, 2019 /PRNewswire/ -- In honor of Veterans Day, Welltower Inc. (NYSE: WELL) today announced that it has signed the Employer Support of the Guard & Reserve ("ESGR") Statement of Support pledging the Company's support for employees serving in the military.

SANTA CLARA, Calif., Nov. 11, 2019 /PRNewswire/ -- Results from a new survey released today by eHealth, Inc. (NASDA

SUGAR LAND, Texas, Nov. 11, 2019 /PRNewswire/ -- QuVa Pharma, Inc. announced today that is has launched a new  flag label design for its syringe product portfolio of compounded sterile products (CSPs) for which it has filed a design patent application.  QuVa Pharma developed these new labels in consultation with its customers and has begun to convert all s

HOUSTON, Nov. 11, 2019 /PRNewswire/ -- DNAtrix, an oncolytic virus immunotherapy company with a proprietary adenovirus platform, today announced that updated data from the CAPTIVE / KEYNOTE-192 study of DNX-2401 (tasadenoturev) with pembrolizumab will be presented at the Society for Neuro-Oncology (SNO) Annual Meeting, held from November 22-24

BALTIMORE, Nov. 11, 2019 /PRNewswire/ -- The U.S. healthcare market saw a 14.4 percent increase in mergers and acquisitions from 2017-2018, fueled by soaring domestic venture capital investment – an all-time high of $130.9 billion invested in U.S.-based startups in 2018 alone. Compounding the pace and complexity of deal flow are sweepi

CHAPPAQUA, N.Y., Nov. 11, 2019 /PRNewswire/ -- BioTheryX, Inc. ("BioTheryX"), a clinical stage biotechnology company creating new classes of drugs for unmet medical needs based on targeted protein degradation and multi-kinase inhibition, today announced the appointment of Peter N. Crnkovich to its Board of Directors.  Since

OCEANSIDE, California, Nov. 11, 2019 /PRNewswire/ -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today the signing of a Letter of Intent with Beijing Regenesis Biotechnology Co. Ltd., of Beijing China to develop and commercialize the anti-aging properties of cord blood plasma combined with NanoStilbene.

TEL AVIV, Israel, Nov. 11, 2019 /PRNewswire/ -- The car industry was among the first to lead the Industry 4.0 initiative, and to use Smart Manufacturing analytics, to reduce manufacturing errors that could cost lives. Mobileye, a world leader in driver assist and autonomous driving technology, which was